Showing results (41-50 of 51) with videos related to
Sort By:
Pageof 6
Journal of Veterinary Internal Medicine|January 28, 2016
Differentiation of Cardiac from Noncardiac Pleural Effusions in Cats using Second-Generation Quantitative and Point-of-Care NT-proBNP MeasurementsM J Hezzell, J E Rush, K Humm, et al.Veterinary Pathology|August 31, 2013
Fatal arrhythmogenic right ventricular cardiomyopathy in 2 related subadult chimpanzees (Pan troglodytes)L J Tong, E J Flach, M N Sheppard, et al.Journal of Veterinary Internal Medicine|March 7, 2007
Double chambered right ventricle in 9 catsH Koffas, V Luis Fuentes, A Boswood, et al.Journal of Veterinary Internal Medicine|April 11, 2015
Prevalence of and risk factors for degenerative mitral valve disease in dogs attending primary-care veterinary practices in EnglandM J Mattin, A Boswood, D B Church, et al.Journal of Veterinary Internal Medicine|October 19, 2013
Prognostic indicators in cats with hypertrophic cardiomyopathyJ R Payne, K Borgeat, D J Connolly, et al.The Journal of Small Animal Practice|September 1, 1996
Intestinal permeability and function in dogs with small intestinal bacterial overgrowthH C Rutgers, R M Batt, F J Proud, et al.Journal of Veterinary Internal Medicine|October 20, 2012
Efficacy of pimobendan in the prevention of congestive heart failure or sudden death in Doberman Pinschers with preclinical dilated cardiomyopathy (the PROTECT Study)N J Summerfield, A Boswood, M R O'Grady, et al.Journal of Veterinary Internal Medicine|September 10, 2013
Longitudinal analysis of quality of life, clinical, radiographic, echocardiographic, and laboratory variables in dogs with myxomatous mitral valve disease receiving pimobendan or benazepril: the QUEST studyJ Häggström, A Boswood, M O'Grady, et al.Journal of Veterinary Internal Medicine|July 22, 2008
Effect of pimobendan or benazepril hydrochloride on survival times in dogs with congestive heart failure caused by naturally occurring myxomatous mitral valve disease: the QUEST studyJ Häggström, A Boswood, M O'Grady, et al.Journal of Veterinary Internal Medicine|December 8, 2017
Longitudinal Analysis of Quality of Life, Clinical, Radiographic, Echocardiographic, and Laboratory Variables in Dogs with Preclinical Myxomatous Mitral Valve Disease Receiving Pimobendan or Placebo: The EPIC StudyA Boswood, S G Gordon, J Häggström, et al.Pageof 6